Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

NCT01587339 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01587339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01587339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
July 31, 2011
Enrollment
6,498 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy